Last reviewed · How we verify

NCT04834492

The Results of Total Hip Arthroplasty in Crowe Type 4 Hips.

Completed Last updated 8 April 2021
What this trial tests

trial testing Total hip arthroplasty in The Results of Total Hip Arthroplasty in Crowe Type 4 Dysplastic Hips in 67 participants. Completed in 30 March 2021.

Timeline
15 July 2020
Primary endpoint
10 February 2021
30 March 2021

Quick facts

Lead sponsorPrivate Ortopedia Hospital, Seyhan Adana
StatusCompleted
Study typeOBSERVATIONAL
Enrollment67
Start date15 July 2020
Primary completion10 February 2021
Estimated completion30 March 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Private Ortopedia Hospital, Seyhan Adana

Who can join

Eligibility, any sex, with The Results of Total Hip Arthroplasty in Crowe Type 4 Dysplastic Hips. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Total hip arthroplasty (THA) performed for developmental dysplasia of the hip (DDH) is a technically difficult procedure with a high complication rate, especially in the presence of completely dislocated hips. This study aimed to evaluate the results of at least 10 years of follow-up results of cementless, ceramic-on-ceramic (CoC) total hip arthroplasty performed with transverse subtrochanteric osteotomy in Crowe type 4 hips.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Total hip arthroplasty

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing